UnitedHealth Group (UNH)
NYSE: UNH
· Real-Time Price · USD
353.64
6.86 (1.98%)
At close: Sep 11, 2025, 3:59 PM
353.93
0.08%
After-hours: Sep 11, 2025, 07:59 PM EDT
UnitedHealth Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optumhealth Revenue | 25.2B | 25.31B | 25.66B | 74.85B | 27.05B | 26.73B | 23.86B | 23.92B | 23B | 18.45B | 18.46B | 17.58B | 16.68B | 14.55B | 13.81B | 13.3B | 12.4B | 10.98B | 10.5B | 9.14B | 9.19B | 1.6B | 17.59B | 15.49B | 14.58B | 1.34B | 13.19B | 12.97B | 12.61B | 33.74B | 11.47B | 11.18B | 10.14B | n/a | 9.22B | 8.69B | 8.58B | n/a | 7.63B | 7.42B | 7.07B | n/a | 6.04B | 5.38B | 5.39B | n/a | 5.15B | 4.97B | 5.07B | 5.52B | 4.26B | 4.21B | 4.06B | 9.92B | 3.62B |
| Optumhealth Revenue Growth | -0.41% | -1.37% | -65.72% | +176.72% | +1.19% | +12.01% | -0.22% | +3.97% | +24.71% | -0.09% | +5.00% | +5.40% | +14.65% | +5.34% | +3.85% | +7.23% | +12.98% | +4.56% | +14.88% | -0.58% | +474.14% | -90.90% | +13.56% | +6.26% | +989.39% | -89.85% | +1.66% | +2.86% | -62.62% | +194.24% | +2.59% | +10.18% | n/a | -100.00% | +6.11% | +1.32% | n/a | -100.00% | +2.72% | +4.96% | n/a | -100.00% | +12.31% | -0.30% | n/a | -100.00% | +3.66% | -1.88% | -8.26% | +29.56% | +1.16% | +3.79% | -59.08% | +173.81% | n/a |
| Unitedhealthcare Revenue | 86.1B | 4.63B | 4.78B | 25.92B | 4.54B | 4.5B | 4.98B | 4.67B | 4.5B | 4.39B | 3.69B | 3.28B | 3.22B | 3.25B | 3.14B | 2.96B | 2.85B | 50.33B | 50.37B | 49.11B | 51.07B | 1.1B | 6.25B | 5.48B | 5.15B | 974M | 5.32B | 5.16B | 4.9B | 10.97B | 4.71B | 4.7B | 4.35B | n/a | 4.3B | 4.18B | 3.96B | n/a | 3.79B | 3.38B | 3.36B | n/a | 3.04B | 3.03B | 3.04B | n/a | 2.1B | 2.06B | 2.02B | 4.36B | 1.89B | 1.76B | 1.75B | 6.01B | 1.64B |
| Unitedhealthcare Revenue Growth | +1759.68% | -3.16% | -81.55% | +470.48% | +0.91% | -9.54% | +6.48% | +3.96% | +2.48% | +18.79% | +12.52% | +1.96% | -0.98% | +3.57% | +6.15% | +3.68% | -94.33% | -0.09% | +2.58% | -3.84% | +4551.00% | -82.42% | +13.88% | +6.49% | +428.75% | -81.70% | +3.22% | +5.27% | -55.36% | +132.85% | +0.36% | +8.00% | n/a | n/a | +2.78% | +5.56% | n/a | n/a | +12.32% | +0.51% | n/a | n/a | +0.36% | -0.43% | n/a | n/a | +2.19% | +1.58% | -53.58% | +130.93% | +7.15% | +0.74% | -70.89% | +267.30% | n/a |
| Optuminsight Revenue | 4.83B | 35.13B | 35.77B | 4.93B | 32.41B | 30.84B | 28.86B | 28.65B | 27.42B | 25.85B | 25.2B | 24.8B | 23.91B | 23.85B | 23.34B | 22.52B | 21.6B | 2.91B | 2.77B | 2.63B | 2.49B | 199M | 44.6B | 46.3B | 43.81B | 163M | 42.33B | 40.99B | 39.01B | 152.15B | 38.66B | 38.2B | 36.13B | n/a | 37.26B | 36.89B | 35.03B | n/a | 35.4B | 19.05B | 17.82B | n/a | 17.1B | 17.05B | 15.91B | n/a | 13.41B | 12.05B | 11.14B | 10.52B | 9.6B | 9.89B | 10.13B | 27.55B | 10.4B |
| Optuminsight Revenue Growth | -86.26% | -1.79% | +625.49% | -84.79% | +5.12% | +6.85% | +0.74% | +4.48% | +6.05% | +2.58% | +1.60% | +3.74% | +0.26% | +2.19% | +3.61% | +4.26% | +642.66% | +5.13% | +5.13% | +5.53% | +1153.27% | -99.55% | -3.68% | +5.69% | +26777.30% | -99.61% | +3.27% | +5.07% | -74.36% | +293.53% | +1.21% | +5.71% | n/a | n/a | +1.00% | +5.32% | n/a | n/a | +85.82% | +6.91% | n/a | n/a | +0.31% | +7.13% | n/a | n/a | +11.33% | +8.13% | +5.89% | +9.62% | -2.97% | -2.33% | -63.24% | +164.80% | n/a |
| Optumrx Revenue | 38.46B | 84.62B | 74.13B | 34.21B | 73.87B | 75.36B | 69.85B | 70.23B | 70.47B | 63.05B | 61.99B | 62.1B | 62.59B | 56.38B | 55.93B | 55.47B | 55.11B | 22.49B | 22.08B | 21.37B | 21.56B | 2.32B | 98.21B | 99B | 99.68B | 2.12B | 93.7B | 93.63B | 92.77B | 316.09B | 83.32B | 83.37B | 82.03B | n/a | 76.13B | 76.83B | 73.45B | n/a | 67.22B | 67.69B | 66.73B | n/a | 61.56B | 61.58B | 59.94B | n/a | 58.27B | 58.07B | 57.81B | n/a | 52.1B | 52.07B | 52.1B | n/a | 48.2B |
| Optumrx Revenue Growth | -54.55% | +14.14% | +116.72% | -53.69% | -1.98% | +7.88% | -0.54% | -0.34% | +11.77% | +1.70% | -0.18% | -0.78% | +11.02% | +0.82% | +0.82% | +0.65% | +145.07% | +1.85% | +3.32% | -0.86% | +829.58% | -97.64% | -0.80% | -0.68% | +4606.28% | -97.74% | +0.08% | +0.92% | -70.65% | +279.37% | -0.06% | +1.63% | n/a | n/a | -0.91% | +4.60% | n/a | n/a | -0.70% | +1.43% | n/a | n/a | -0.03% | +2.73% | n/a | n/a | +0.35% | +0.44% | n/a | n/a | +0.06% | -0.06% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |